Please distribute this information to all practice staff
Key points

1. The Therapeutic Goods Administration (TGA) has approved the use of Panvax (multi-dose vials) for people aged 6 months and above.
2. Practices may now start vaccinating children aged 6 months and above with Panvax (MDV).
3. The TGA has also approved the use of Panvax Junior (pre-filled syringe) for children aged 6 months to less than 3 years.
4. Distribution of Panvax Junior is expected to commence shortly.
5. While two doses of vaccine are recommended for children under 10 years of age, one dose may provide a good protective boost against pandemic influenza.

	NSW Department of Health - H1N1 Vaccination Update for GPs and AMS (Updated Dec 2009)
	H1N1 Information Sheet - Use in Children (Updated Dec 2009)
	Health Professional Information Sheet (Updated Dec 2009)
	Health Professional Summary Sheet (Updated Dec 2009)
	GPs and Aboriginal Medical Service Vaccine Order Form (Updated Dec 2009)